| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 76.27B | 65.01B | 69.03B | 62.20B | 61.38B |
| Gross Profit | 9.77B | 8.81B | 9.64B | 9.54B | 10.30B |
| EBITDA | 1.61B | 1.62B | 3.45B | 3.01B | 3.63B |
| Net Income | 386.09M | 568.00M | 1.07B | 827.00M | 1.63B |
Balance Sheet | |||||
| Total Assets | 85.21B | 70.01B | 67.16B | 72.32B | 74.47B |
| Cash, Cash Equivalents and Short-Term Investments | 15.32B | 9.46B | 9.83B | 10.10B | 12.15B |
| Total Debt | 20.34B | 16.40B | 15.46B | 17.24B | 19.87B |
| Total Liabilities | 59.53B | 46.87B | 44.40B | 47.73B | 48.68B |
| Stockholders Equity | 19.47B | 18.24B | 18.14B | 20.06B | 22.07B |
Cash Flow | |||||
| Free Cash Flow | 314.51M | -1.74B | 660.00M | 3.02B | -1.12B |
| Operating Cash Flow | 1.84B | -506.00M | 2.48B | 5.89B | 1.40B |
| Investing Cash Flow | -2.20B | 17.00M | -352.00M | -5.05B | -1.22B |
| Financing Cash Flow | 1.23B | -263.00M | -2.21B | -1.66B | 2.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$801.80B | 22.33 | 16.22% | ― | 35.67% | 122.22% | |
66 Neutral | HK$36.07B | 10.04 | 9.56% | 2.96% | 21.26% | 94.52% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | HK$260.61M | -22.59 | -11.38% | 8.70% | -16.95% | -461.16% | |
54 Neutral | HK$2.40B | 38.27 | 19.27% | 0.50% | 11.29% | 40.42% | |
48 Neutral | HK$11.65B | 24.30 | 2.01% | ― | 6.10% | -70.77% | |
40 Underperform | HK$199.16M | -3.41 | -13.04% | ― | 8.62% | -24.87% |